RevaTis is led by Prof. Didier Serteyn,
head of the Equine Clinic of the University of Liège
• 4 persons on the payroll in Belgium
• 1 person in place in the USA
• 1 person in place in HK
• 3 Searchers University Liege (senior scientist, PhD student, technician)
• Consultants: Marketing (H. Spiessens), Regulatory (A. Dufour)
Didier Serteyn is graduated doctor in veterinary medicine from the University of Liege in 1982 and obtained his PhD in 1989. As full Professor of equine anesthesia, surgery and intensive care, he is the head of the equine clinic of the Faculty of Veterinary Medicine.
His applied research activities have brought essential knowledge in pathologies such as myopathy, laminitis, colic but also orthopedic developmental (osteochondrosis) and degenerative pathologies (osteoarthritis).
The themes of more fundamental research are related to mitochondrial dysfunction, inflammation and regenerative medicine. He is author or co-author of more than 250 scientific papers published in peer- reviewed journals and 3 patents transferred to spin-off companies.
Didier Serteyn with Justine Ceusters and Jean-Philippe Lejeune are the founders of RevaTis, a spin-off
company of the University of Liege dedicated to cell therapy and veterinary regenerative medicine.